Combination of body mass index and albumin predicts the survival in metastatic castration-resistant prostate cancer patients treated with abiraterone: A post hoc analysis of two randomized trials

Citation:

Pan J, Wang J, Wei Y, Zhang T, Zhang S, Ye D, Zhu Y. Cancer Med. 2021 Aug 20. doi: 10.1002/cam4.4205. Epub ahead of print. PMID: 34414685.